Results 21 to 30 of about 3,367,527 (366)

Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments

Journal of Pharmaceutical Health Care and Sciences, 2017
Background Medical gloves are an important piece of personal protective equipment that prevents exposure to antineoplastic agents. The permeability of medical gloves to antineoplastic agents is a crucial factor in the appropriate selection of gloves ...
Toyohito Oriyama, Takehito Yamamoto, Yoshitsugu Yanagihara, Katsuhiko Nara, Toshihide Abe, Katsuyoshi Nakajima, Takao Aoyama, Hiroshi Suzuki   +7 more
doaj   +2 more sources

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database [PDF]

Therapeutic Advances in Drug Safety
Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between ...
Dongxuan Li, Chunmeng Qin, Hongli Wang, Dan Du, Yalan Wang, Qian Du, Songqing Liu   +6 more
doaj   +2 more sources

Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties [PDF]

Journal of Pharmaceutical Health Care and Sciences, 2020
Background Permeability of antineoplastic agents through medical gloves is an important factor that must be considered for the appropriate selection of gloves.
Toyohito Oriyama, Takehito Yamamoto, Katsuhiko Nara, Yohei Kawano, Katsuyoshi Nakajima, Hiroshi Suzuki, Takao Aoyama   +6 more
doaj   +2 more sources

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance studyResearch in context [PDF]

EClinicalMedicine
Summary: Background: Studies have shown that some antineoplastic agents may be associated with interstitial lung disease (ILD), but large-scale real-world data are lacking.
Zijun Zhu, Yongxin Li, Chaoyong Zhu, Qiuxia Dong, Yixiao Zhang, Zhilin Liu, Dengfeng Ren, Fuxing Zhao, Jiuda Zhao   +8 more
doaj   +2 more sources

Mucocutaneous Reactions to Antineoplastic Agents [PDF]

CA: A Cancer Journal for Clinicians, 1980
Mucocutaneous reaction patterns in patients receiving cancer therapy are not only variable, but in many instances identical patterns are produced by different pathologic mechanisms. For example, patients with leukemia or lymphoma may present with nodular skin lesions that may represent malignant infiltration, septic emboli, vasculitis, or a drug ...
Robert M. Adrian, Arthur T. Skarin, Antoinette F. Hood   +2 more
openaire   +4 more sources

Drug–Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms

Clinical and Applied Thrombosis/Hemostasis, 2020
Data on drug–drug interactions (DDI) of antineoplastic drugs with anticoagulants is scarce. We aim to evaluate factors associated with DDI of antineoplastic and supportive care drugs with anticoagulants resulting in modification of pharmacokinetics of ...
Érique José F. Peixoto de Miranda MD, PhD, Thamy Takahashi Pharm B., Felipe Iwamoto Pharm B., Suzete Yamashiro DDS, Eliana Samano MD, MBA, Ariane Vieira Scarlatelli Macedo MD, MSc, Eduardo Ramacciotti MD, PhD   +6 more
doaj   +2 more sources

Extravasation of antineoplastic agents: prevention and treatments

Pediatric Reports, 2012
The extravasation of antineoplastic agents is an unwanted and distressing situation that can easily occur. It may cause severe and irreversible local injuries.
Rita Boschi, Elena Rostagno
doaj   +2 more sources

Renal toxicity of antineoplastic agents

Toxicology Letters, 1990
Most of the drugs currently used in the treatment of cancer are highly cytotoxic and possess relatively low therapeutic selectivity. Given the major role of the kidney in the excretion of these drugs or their metabolites, it is perhaps surprising that clinically significant nephrotoxicity occurs with a limited number of drugs.
Richard F. Borch, Thomas J. Montine
openaire   +4 more sources

Antineoplastic Agents Action and Toxicities [PDF]

AAOHN Journal, 1986
Bonnie Rogers
openaire   +3 more sources

Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (Review)

International Journal of Oncology, 2014
Targeting the oxygen stress response pathway is considered a promising strategy to exert antineoplastic activity in a broad spectrum of tumor types.
HANS MÖHLER, ROLF W. PFIRMAN, Karl Frei
openalex   +3 more sources